• Home
  • Huntington’s disease
  • important
  • Articles
    • Scientific Articles Free
    • Italian articles
  • ARTICLES SCIENTIFIC
  • Link
Search
  • Contact
  • Sitemap
  • Donate
  • Newsletters
  • www.aichroma.com
  • Italian | Español | French

Huntington's Disease News

  • Home
  • Huntington’s disease
  • important
    • Ionis’ partner to evaluate tominersen for Huntington’s disease in new Phase…

      A new mechanism that stops the progression of Huntington’s disease in…

      uniQure Announces Publications of Preclinical Data for AMT-130 in Huntington’s Disease…

      uniQure Announces Completion of Enrollment in First Cohort of Phase I/II…

      Roche provides update on tominersen programme in manifest Huntington’s disease

  • Articles
    • Scientific Articles Free
    • Italian articles
  • ARTICLES SCIENTIFIC
  • Link

Triplet Therapeutics Presents Preclinical Data for TTX-3360, Announces Equity Pledge at...

Apr 28, 2021

Huntington’s disease therapeutics conference 2021 – Day 1

Apr 28, 2021

Huntington’s disease clinical trial round up

Apr 27, 2021

Good news from uniQure: gene therapy trial on track, and promising...

Apr 16, 2021

A NEW INTERNATIONAL CONSORTIUM TO PROMOTE STEM CELL-BASED THERAPY FOR HUNTINGTON’S...

Apr 10, 2021

uniQure Announces Publications of Preclinical Data for AMT-130 in Huntington’s Disease...

Apr 8, 2021

uniQure Announces Completion of Enrollment in First Cohort of Phase I/II...

Apr 6, 2021

Disappointing Results from Wave’s PRECISION-HD1 and 2 Trials

Mar 31, 2021

Wave Life Sciences fornisce aggiornamenti sulle prove PRECISION-HD di fase 1b...

Mar 31, 2021

Sad News from Roche and Ionis – ASO Trial Halted Early

Mar 27, 2021
123...130Page 2 of 130
ABOUT US
AICH - ROMA ONLUS: VIA NOMENTANA 56, 00161 ROMA TEL/FAX 06.44242033 c/c postale n. 35453000 C.F. 96152570584
FOLLOW US
  • Discliminair
  • Contact
  • Donate
  • Sitemap
© newshd.net
This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish.Accept Discliminair
Privacy & Cookies Policy

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary
Sempre abilitato
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Non-necessary
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.
ACCETTA E SALVA